Page last updated: 2024-12-11

crepenynic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

crepenynic acid: oxidized form of linoleic acid; precursor to C14 and pentaynene acetylenes in COMPOSITAE; potential inhibitor of essential fatty acid metabolism; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5461139
CHEBI ID14030
MeSH IDM0136296

Synonyms (9)

Synonym
(z)-9-octadecen-12-ynoate
CHEBI:14030 ,
cis-9-octadecen-12-ynoate
(9z)-octadec-9-en-12-ynoate
crepenynate ,
crepenynic acid
(z)-9-octadecen-12-ynoic acid
(z)-octadec-9-en-12-ynoate
Q27108974
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
long-chain fatty acid anionA fatty acid anion with a chain length of C13 to C22.
straight-chain fatty acid anionA fatty acid anion formed by deprotonation of the carboxylic acid functional group of a straight-chain fatty acid.
unsaturated fatty acid anionAny fatty acid anion containing at least one C-C unsaturated bond; formed by deprotonation of the carboxylic acid moiety.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
crepenynic acid biosynthesis05

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.62 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]